Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,188 | 66,764 | 61,207 | 61,233 | 69,093 |
| Marketable Securities | 133,797 | 138,217 | 159,845 | 168,757 | 169,545 |
| Receivables | 12,452 | 15,680 | 17,679 | 23,227 | 25,543 |
| Inventories | 14,290 | 14,623 | 12,852 | 10,755 | 10,345 |
| TOTAL | $222,354 | $256,532 | $272,605 | $284,344 | $297,035 |
| Non-Current Assets | |||||
| PPE Net | 3,741 | 4,264 | 4,407 | 4,682 | 4,440 |
| Other Non-Current Assets | 672 | 719 | 5,486 | 7,101 | 7,621 |
| TOTAL | $4,413 | $4,983 | $9,893 | $11,783 | $12,061 |
| Total Assets | $226,767 | $261,515 | $282,498 | $296,127 | $309,096 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29,601 | 17,393 | 12,394 | 3,288 | 27,417 |
| Accounts payable and accrued liabilities | 3,079 | 3,578 | 4,641 | 3,650 | 6,211 |
| Accrued Expenses | 24,935 | 28,821 | 25,733 | 23,851 | 21,791 |
| TOTAL | $61,708 | $54,585 | $52,660 | $38,885 | $64,223 |
| Non-Current Liabilities | |||||
| Long Term Debt | 184,430 | 199,228 | 199,803 | 204,850 | 168,600 |
| Deferred Revenues | 4,093 | 4,793 | 9,892 | 8,096 | 8,804 |
| Other Non-Current Liabilities | 326 | 358 | 1,178 | 600 | 3,906 |
| TOTAL | $223,558 | $239,411 | $241,830 | $247,322 | $215,401 |
| Total Liabilities | $285,266 | $293,996 | $294,490 | $286,207 | $279,624 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 129,840 | 129,764 | 129,490 | 129,414 | 129,140 |
| Common Shares | 130 | 130 | 129 | 129 | 129 |
| Retained earnings | -618,239 | -585,342 | -557,955 | -529,010 | -502,135 |
| Other shareholders' equity | -49 | -6 | 83 | 216 | 88 |
| TOTAL | $-58,499 | $-32,481 | $-11,992 | $9,920 | $29,472 |
| Total Liabilities And Equity | $226,767 | $261,515 | $282,498 | $296,127 | $309,096 |